LeishMANIAdb
  • Home
  • Browse
  • Manual
  • FAQ
  • Download

3-oxo-5-alpha-steroid 4-dehydrogenase-like protein

Quick info Annotations Function or PPIs Localization Expansion Sequence features Structure Function Putative motif mimicry Homologs Download

Quick info

Protein:
3-oxo-5-alpha-steroid 4-dehydrogenase-like protein
Gene product:
3-oxo-5-alpha-steroid 4-dehydrogenase-like protein
Species:
Leishmania major
UniProt:
Q4QE81_LEIMA
TriTrypDb:
LmjF.17.1100 , LMJLV39_170018300 , LMJSD75_170018000
Length:
543

Annotations

LeishMANIAdb annotations

Related to other eukaryotic steroid 5 alpha reductases. Localization: ER (by homology)

Localization

Secreted promastigote
Source Evidence on protein Close homologs
Cuervo et al. no yes: 0
Hassani et al. no yes: 0
Forrest at al. (metacyclic) no yes: 0
Forrest at al. (procyclic) no yes: 0
Silverman et al. no yes: 0
Pissara et al. no yes: 0
Secreted amastigote
Source Evidence on protein Close homologs
Pires et al. no yes: 0
Exosome
Source Evidence on protein Close homologs
Silverman et al. no yes: 0
Glycosome
Source Evidence on protein Close homologs
Jamdhade et al. no yes: 0
Predictions
Source Evidence on protein Close homologs
DeepLoc
SignalP6 no yes: 0, no: 6
NetGPI no yes: 0, no: 6
Cellular components
Term Name Level Count
GO:0016020 membrane 2 7
GO:0110165 cellular anatomical entity 1 7

Expansion

Sequence features

Q4QE81
Sequence
MSA
Disorder
Secondary
Topology
Domains
SignalP
GPI
Phosphorylations
ELMs

Structure

Predicted structure by AlphaFold2

Related structures:

AlphaFold database: Q4QE81

Function

Biological processes
Term Name Level Count
GO:0006629 lipid metabolic process 3 7
GO:0008152 metabolic process 1 7
GO:0044238 primary metabolic process 2 7
GO:0071704 organic substance metabolic process 2 7
Molecular functions
Term Name Level Count
GO:0003824 catalytic activity 1 7
GO:0003865 3-oxo-5-alpha-steroid 4-dehydrogenase activity 5 6
GO:0016229 steroid dehydrogenase activity 3 6
GO:0016491 oxidoreductase activity 2 7
GO:0016627 oxidoreductase activity, acting on the CH-CH group of donors 3 7
GO:0033765 steroid dehydrogenase activity, acting on the CH-CH group of donors 4 6

Putative motif mimicry

Leishmania From To Domain/Motif Score
CLV_C14_Caspase3-7 404 408 PF00656 0.574
CLV_C14_Caspase3-7 84 88 PF00656 0.682
CLV_MEL_PAP_1 135 141 PF00089 0.576
CLV_NRD_NRD_1 361 363 PF00675 0.437
CLV_NRD_NRD_1 378 380 PF00675 0.496
CLV_PCSK_FUR_1 359 363 PF00082 0.445
CLV_PCSK_KEX2_1 361 363 PF00082 0.438
CLV_PCSK_KEX2_1 378 380 PF00082 0.492
CLV_PCSK_SKI1_1 300 304 PF00082 0.545
CLV_PCSK_SKI1_1 485 489 PF00082 0.450
CLV_PCSK_SKI1_1 535 539 PF00082 0.346
CLV_Separin_Metazoa 460 464 PF03568 0.590
DEG_APCC_DBOX_1 225 233 PF00400 0.403
DEG_APCC_DBOX_1 299 307 PF00400 0.478
DEG_SPOP_SBC_1 175 179 PF00917 0.533
DEG_SPOP_SBC_1 389 393 PF00917 0.793
DEG_SPOP_SBC_1 464 468 PF00917 0.671
DOC_ANK_TNKS_1 402 409 PF00023 0.486
DOC_CDC14_PxL_1 157 165 PF14671 0.437
DOC_CYCLIN_yCln2_LP_2 232 238 PF00134 0.471
DOC_CYCLIN_yCln2_LP_2 60 66 PF00134 0.574
DOC_MAPK_DCC_7 226 234 PF00069 0.365
DOC_MAPK_MEF2A_6 322 331 PF00069 0.409
DOC_PP1_RVXF_1 136 142 PF00149 0.422
DOC_PP1_RVXF_1 320 326 PF00149 0.345
DOC_PP1_RVXF_1 483 489 PF00149 0.450
DOC_PP1_RVXF_1 92 98 PF00149 0.635
DOC_PP2B_LxvP_1 133 136 PF13499 0.477
DOC_PP2B_LxvP_1 232 235 PF13499 0.385
DOC_PP2B_LxvP_1 60 63 PF13499 0.580
DOC_PP4_FxxP_1 64 67 PF00568 0.687
DOC_SPAK_OSR1_1 115 119 PF12202 0.512
DOC_USP7_MATH_1 175 179 PF00917 0.542
DOC_USP7_MATH_1 277 281 PF00917 0.539
DOC_USP7_MATH_1 302 306 PF00917 0.437
DOC_USP7_MATH_1 312 316 PF00917 0.393
DOC_USP7_MATH_1 387 391 PF00917 0.747
DOC_USP7_MATH_1 440 444 PF00917 0.615
DOC_USP7_MATH_1 464 468 PF00917 0.671
DOC_USP7_MATH_1 90 94 PF00917 0.641
DOC_WW_Pin1_4 143 148 PF00397 0.325
DOC_WW_Pin1_4 164 169 PF00397 0.477
DOC_WW_Pin1_4 281 286 PF00397 0.555
DOC_WW_Pin1_4 305 310 PF00397 0.437
LIG_14-3-3_CanoR_1 115 121 PF00244 0.411
LIG_14-3-3_CanoR_1 124 130 PF00244 0.463
LIG_14-3-3_CanoR_1 138 142 PF00244 0.327
LIG_14-3-3_CanoR_1 206 216 PF00244 0.428
LIG_14-3-3_CanoR_1 279 287 PF00244 0.457
LIG_14-3-3_CanoR_1 403 407 PF00244 0.456
LIG_14-3-3_CanoR_1 463 473 PF00244 0.647
LIG_14-3-3_CanoR_1 81 89 PF00244 0.709
LIG_14-3-3_CanoR_1 98 106 PF00244 0.475
LIG_Actin_WH2_2 8 25 PF00022 0.450
LIG_Actin_WH2_2 99 117 PF00022 0.512
LIG_APCC_ABBA_1 32 37 PF00400 0.673
LIG_APCC_ABBA_1 381 386 PF00400 0.627
LIG_BIR_II_1 1 5 PF00653 0.459
LIG_BRCT_BRCA1_1 127 131 PF00533 0.433
LIG_BRCT_BRCA1_1 339 343 PF00533 0.512
LIG_BRCT_BRCA1_1 98 102 PF00533 0.546
LIG_CSL_BTD_1 60 63 PF09270 0.580
LIG_deltaCOP1_diTrp_1 57 64 PF00928 0.751
LIG_FHA_1 103 109 PF00498 0.431
LIG_FHA_1 16 22 PF00498 0.459
LIG_FHA_1 431 437 PF00498 0.618
LIG_FHA_1 452 458 PF00498 0.601
LIG_FHA_2 235 241 PF00498 0.429
LIG_FHA_2 453 459 PF00498 0.671
LIG_FHA_2 523 529 PF00498 0.618
LIG_Integrin_isoDGR_2 256 258 PF01839 0.564
LIG_Integrin_RGD_1 362 364 PF01839 0.469
LIG_LIR_Apic_2 227 231 PF02991 0.375
LIG_LIR_Apic_2 407 412 PF02991 0.574
LIG_LIR_Gen_1 110 118 PF02991 0.461
LIG_LIR_Gen_1 148 158 PF02991 0.416
LIG_LIR_Gen_1 18 26 PF02991 0.465
LIG_LIR_Gen_1 250 259 PF02991 0.372
LIG_LIR_Gen_1 433 441 PF02991 0.576
LIG_LIR_Gen_1 468 478 PF02991 0.618
LIG_LIR_Gen_1 528 538 PF02991 0.618
LIG_LIR_LC3C_4 240 245 PF02991 0.424
LIG_LIR_Nem_3 110 114 PF02991 0.461
LIG_LIR_Nem_3 148 153 PF02991 0.383
LIG_LIR_Nem_3 159 163 PF02991 0.430
LIG_LIR_Nem_3 18 22 PF02991 0.465
LIG_LIR_Nem_3 200 205 PF02991 0.408
LIG_LIR_Nem_3 250 255 PF02991 0.378
LIG_LIR_Nem_3 354 358 PF02991 0.580
LIG_LIR_Nem_3 431 435 PF02991 0.493
LIG_LIR_Nem_3 467 473 PF02991 0.705
LIG_LIR_Nem_3 502 506 PF02991 0.411
LIG_LIR_Nem_3 525 529 PF02991 0.543
LIG_LIR_Nem_3 59 64 PF02991 0.705
LIG_LYPXL_yS_3 160 163 PF13949 0.482
LIG_MYND_1 171 175 PF01753 0.531
LIG_MYND_1 63 67 PF01753 0.690
LIG_NRBOX 213 219 PF00104 0.449
LIG_PCNA_PIPBox_1 248 257 PF02747 0.419
LIG_Pex14_1 127 131 PF04695 0.492
LIG_SH2_CRK 111 115 PF00017 0.450
LIG_SH2_CRK 409 413 PF00017 0.546
LIG_SH2_CRK 530 534 PF00017 0.618
LIG_SH2_PTP2 435 438 PF00017 0.546
LIG_SH2_SRC 435 438 PF00017 0.618
LIG_SH2_STAP1 287 291 PF00017 0.454
LIG_SH2_STAP1 522 526 PF00017 0.618
LIG_SH2_STAT3 72 75 PF00017 0.648
LIG_SH2_STAT5 223 226 PF00017 0.363
LIG_SH2_STAT5 24 27 PF00017 0.644
LIG_SH2_STAT5 252 255 PF00017 0.374
LIG_SH2_STAT5 287 290 PF00017 0.499
LIG_SH2_STAT5 33 36 PF00017 0.643
LIG_SH2_STAT5 356 359 PF00017 0.589
LIG_SH2_STAT5 435 438 PF00017 0.546
LIG_SH2_STAT5 506 509 PF00017 0.411
LIG_SH2_STAT5 530 533 PF00017 0.618
LIG_SH2_STAT5 72 75 PF00017 0.577
LIG_SH3_3 115 121 PF00018 0.411
LIG_SH3_3 165 171 PF00018 0.479
LIG_SUMO_SIM_par_1 104 110 PF11976 0.512
LIG_SUMO_SIM_par_1 240 246 PF11976 0.391
LIG_TRAF2_1 456 459 PF00917 0.593
LIG_TRAF2_1 67 70 PF00917 0.736
LIG_TYR_ITIM 158 163 PF00017 0.579
LIG_TYR_ITSM 431 438 PF00017 0.512
MOD_CK1_1 137 143 PF00069 0.469
MOD_CK1_1 169 175 PF00069 0.637
MOD_CK1_1 178 184 PF00069 0.661
MOD_CK1_1 190 196 PF00069 0.520
MOD_CK1_1 281 287 PF00069 0.584
MOD_CK1_1 305 311 PF00069 0.628
MOD_CK1_1 390 396 PF00069 0.585
MOD_CK1_1 443 449 PF00069 0.599
MOD_CK1_1 452 458 PF00069 0.434
MOD_CK1_1 466 472 PF00069 0.396
MOD_CK1_1 49 55 PF00069 0.562
MOD_CK2_1 389 395 PF00069 0.651
MOD_CK2_1 452 458 PF00069 0.550
MOD_CK2_1 486 492 PF00069 0.486
MOD_CMANNOS 58 61 PF00535 0.667
MOD_Cter_Amidation 376 379 PF01082 0.736
MOD_GlcNHglycan 1 4 PF01048 0.577
MOD_GlcNHglycan 178 181 PF01048 0.707
MOD_GlcNHglycan 193 196 PF01048 0.403
MOD_GlcNHglycan 263 266 PF01048 0.573
MOD_GlcNHglycan 27 30 PF01048 0.652
MOD_GlcNHglycan 280 283 PF01048 0.638
MOD_GlcNHglycan 310 313 PF01048 0.685
MOD_GlcNHglycan 339 342 PF01048 0.512
MOD_GlcNHglycan 40 43 PF01048 0.478
MOD_GlcNHglycan 442 445 PF01048 0.555
MOD_GlcNHglycan 488 491 PF01048 0.513
MOD_GlcNHglycan 83 86 PF01048 0.661
MOD_GlcNHglycan 99 102 PF01048 0.249
MOD_GSK3_1 174 181 PF00069 0.684
MOD_GSK3_1 187 194 PF00069 0.570
MOD_GSK3_1 230 237 PF00069 0.488
MOD_GSK3_1 243 250 PF00069 0.448
MOD_GSK3_1 273 280 PF00069 0.695
MOD_GSK3_1 281 288 PF00069 0.641
MOD_GSK3_1 304 311 PF00069 0.618
MOD_GSK3_1 387 394 PF00069 0.732
MOD_GSK3_1 439 446 PF00069 0.443
MOD_GSK3_1 465 472 PF00069 0.645
MOD_GSK3_1 486 493 PF00069 0.614
MOD_N-GLC_1 446 451 PF02516 0.510
MOD_NEK2_1 102 107 PF00069 0.460
MOD_NEK2_1 116 121 PF00069 0.600
MOD_NEK2_1 131 136 PF00069 0.610
MOD_NEK2_1 15 20 PF00069 0.507
MOD_NEK2_1 243 248 PF00069 0.482
MOD_NEK2_1 337 342 PF00069 0.482
MOD_NEK2_1 388 393 PF00069 0.723
MOD_NEK2_1 451 456 PF00069 0.513
MOD_NEK2_1 465 470 PF00069 0.539
MOD_NEK2_2 247 252 PF00069 0.469
MOD_PIKK_1 166 172 PF00454 0.447
MOD_PIKK_1 207 213 PF00454 0.494
MOD_PIKK_1 65 71 PF00454 0.591
MOD_PKA_2 123 129 PF00069 0.586
MOD_PKA_2 137 143 PF00069 0.385
MOD_PKA_2 278 284 PF00069 0.584
MOD_PKA_2 402 408 PF00069 0.409
MOD_PKA_2 80 86 PF00069 0.645
MOD_PKA_2 97 103 PF00069 0.336
MOD_Plk_4 137 143 PF00069 0.469
MOD_Plk_4 145 151 PF00069 0.448
MOD_Plk_4 15 21 PF00069 0.512
MOD_Plk_4 169 175 PF00069 0.659
MOD_Plk_4 197 203 PF00069 0.525
MOD_Plk_4 247 253 PF00069 0.453
MOD_Plk_4 466 472 PF00069 0.573
MOD_ProDKin_1 143 149 PF00069 0.380
MOD_ProDKin_1 164 170 PF00069 0.603
MOD_ProDKin_1 281 287 PF00069 0.698
MOD_ProDKin_1 305 311 PF00069 0.535
TRG_DiLeu_BaEn_1 159 164 PF01217 0.564
TRG_ENDOCYTIC_2 111 114 PF00928 0.512
TRG_ENDOCYTIC_2 154 157 PF00928 0.575
TRG_ENDOCYTIC_2 160 163 PF00928 0.502
TRG_ENDOCYTIC_2 252 255 PF00928 0.450
TRG_ENDOCYTIC_2 355 358 PF00928 0.465
TRG_ENDOCYTIC_2 435 438 PF00928 0.411
TRG_ENDOCYTIC_2 530 533 PF00928 0.411
TRG_ER_diArg_1 358 361 PF00400 0.510
TRG_Pf-PMV_PEXEL_1 23 27 PF00026 0.589

Homologs

Protein Taxonomy Sequence identity Coverage
A0A0N0P837 Leptomonas seymouri 46% 100%
A0A3S7WUK3 Leishmania donovani 91% 100%
A4H965 Leishmania braziliensis 72% 100%
A4HXI7 Leishmania infantum 92% 100%
E9AR82 Leishmania mexicana (strain MHOM/GT/2001/U1103) 85% 100%

Download

Download
LeishMANIAdb - Server version: v0.0.2. - Database version: v0.0.1. - ChangeLog - © 2022-2025 Protein Bioinformatics Research Group, Institute of Enzymology, RCNS